BIO - Bio-Rad Laboratories, Inc.

NYSE - NYSE Prezzo differito. Valuta in USD.
359,49
-13,07 (-3,51%)
Alla chiusura: 04:03PM EDT
364,70 +5,21 (+1,45%)
Dopo ore: 07:58PM EDT
Il grafico dei titoli non è supportato dal tuo browser attuale
Chiusura precedente372,56
Aperto370,92
Denaro359,57 x 800
Lettera370,40 x 800
Min-Max giorno359,45 - 370,92
Intervallo di 52 settimane344,63 - 572,70
Volume205.850
Media Volume195.117
Capitalizzazione10,447B
Beta (5 anni mensile)0,91
Rapporto PE (ttm)N/D
EPS (ttm)-7,01
Prossima data utili26 lug 2023 - 31 lug 2023
Rendimento e dividendo (forward)N/D (N/D)
Data ex dividendoN/D
Stima target 1A560,20
  • GlobeNewswire

    Cytek® Biosciences Partners with Bio-Rad to Expand Reagent Portfolios

    New Agreement Enhances High-Parameter Panels on Cytek Cell Analysis SystemsFREMONT, Calif., Feb. 07, 2023 (GLOBE NEWSWIRE) -- Delivering a boost to immuno-oncology and immunotherapy researchers, Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced that it has entered into a strategic partnership with leading life science research and clinical diagnostics products company Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb). Under the terms of the agreement, Bio-Rad’s exceptionally bright, high-perf